Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UHRF1 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-16 |
mRNA | RAG1 | GDSC1000 | pan-cancer | AAC | 0.29 | 9e-16 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-15 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-15 |
mRNA | KCNRG | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-15 |
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-15 |
mRNA | TMED9 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-15 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-15 |
mRNA | ZBTB39 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-15 |
mRNA | LUC7L | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-15 |